Related Experiment Video
Updated: Feb 11, 2026

A BW Reporter System for Studying Receptor-Ligand Interactions
Published on: January 7, 2019
pH protective Y1 receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and
Zhenqi Jiang1, Yuchen Tian2, Dingying Shan3
1CAS Key Laboratory of Magnetic Materials and Devices, Key Laboratory of Additive Manufacturing Materials of Zhejiang Province, Division of Functional Materials and Nanodevices, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Abstract:
Nanoparticle-based tumor therapies are extensively studied; however, few are capable of improving patient survival time due to premature drug leakage, off target effects, and poor tissue penetration. Previously, we successfully synthesized a novel family of Y1 receptor (Y1R) ligand modified, photoluminescent BPLP nanobubbles and nanoparticles for targeted breast cancer ultrasound imaging; however, increased accumulation could also be observed in the liver, kidney, and spleen, suggesting significant interaction of the particles with macrophages in vivo. Herein, for the first time, we imparted antiphagocytosis capability to Y1R ligand functionalized BPLP-WPU polymeric micelles through the incorporation of a CD47 human glycoprotein based self-peptide. Application of self-peptide modified, DOX loaded micelles in vivo resulted in a 100% survival rate and complete tumor necrosis over 100 days of treatment. In vivo imaging of SPION loaded, self-peptide modified micelles revealed effective targeting to the tumor site while analysis of iron content demonstrated reduced particle accumulation in the liver and kidney, demonstrating reduced macrophage interaction, as well as a 2-fold increase of particles in the tumor. As these results demonstrate, Y1R ligand, self-peptide modified BPLP-WPU micelles are capable of target specific cancer treatment and imaging, making them ideal candidates to improve survival rate and tumor reduction clinically.
Insights
Novel Y1 receptor ligand functionalized nanoparticles with antiphagocytosis properties significantly improved breast cancer treatment outcomes, achieving a 100% survival rate and complete tumor necrosis in vivo.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Nanoparticle drug delivery faces challenges like premature drug leakage, off-target effects, and poor tissue penetration, limiting therapeutic efficacy.
- Previous Y1 receptor (Y1R) ligand-modified nanoparticles showed promise in breast cancer imaging but accumulated in off-target organs due to macrophage interactions.
- Macrophages can clear nanoparticles, reducing their accumulation at the tumor site and overall therapeutic effectiveness.
Purpose of the Study:
- To develop Y1R ligand-functionalized polymeric micelles with enhanced tumor targeting and reduced off-target accumulation.
- To impart antiphagocytosis capability to nanoparticles by incorporating a CD47 self-peptide to evade macrophage clearance.
- To evaluate the in vivo efficacy and biodistribution of these novel micelles for breast cancer therapy and imaging.
Main Methods:
- Synthesis of Y1R ligand-functionalized BPLP-WPU polymeric micelles.
- Incorporation of a CD47 human glycoprotein-based self-peptide to confer antiphagocytosis properties.
- In vivo administration of DOX-loaded micelles for therapeutic evaluation and SPION-loaded micelles for imaging and biodistribution studies.
Main Results:
- Self-peptide modified, DOX-loaded micelles achieved a 100% survival rate and complete tumor necrosis in vivo over 100 days.
- In vivo imaging confirmed effective tumor targeting of SPION-loaded, self-peptide modified micelles.
- Biodistribution analysis showed reduced particle accumulation in the liver and kidney, indicating decreased macrophage interaction, and a twofold increase in tumor accumulation.
Conclusions:
- Y1R ligand and self-peptide co-modified BPLP-WPU micelles represent a promising strategy for targeted cancer therapy and imaging.
- The antiphagocytosis capability significantly enhances nanoparticle accumulation at the tumor site, improving therapeutic outcomes.
- These engineered micelles hold potential for clinical translation to improve patient survival and achieve tumor reduction.
Related Concept Videos
Ligand Binding and Linkage
Internal Receptors
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
G-protein Coupled Receptors

